The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EORTC CLTF 2021 | Unmet needs in early-stage mycosis fungoides
Maarten Vermeer, MD, PhD, Leiden University Medical Center, Leiden, Netherlands, talks on the management of early-stage mycosis fungoides, discussing the initial use of local therapies such as steroids and radiotherapy, but outlining the need for systemic therapies where there is lymph node, organ or blood involvement. Dr Vermeer comments on the need for more efficacious systemic therapies in these instances. This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.
